Previous Close | 1.4700 |
Open | 1.7000 |
Bid | 1.3400 |
Ask | 1.6600 |
Strike | 95.00 |
Expire Date | 2023-06-16 |
Day's Range | 1.4700 - 1.7000 |
Contract Range | N/A |
Volume | |
Open Interest | 798 |
NORTHAMPTON, MA / ACCESSWIRE / February 1, 2023 / Abbott Abbott Go ahead, call it a comeback. There's new energy around connecting - whether among people or technologies - thanks to the not-so-distant pandemic lockdowns that reminded the world ...
They don't offer the highest yields, but these strongly profitable businesses are poised to raise their payouts at a blistering pace.
The U.S. Food and Drug Administration (FDA) said on Tuesday it will restructure its food program that was slammed last year for responding too slowly to an outbreak of illness among infants who consumed formula from an Abbott Laboratories production plant. In response to recommendations made by an outside group following the crisis, the FDA will establish a Human Foods Program led by a deputy commissioner, uniting its Center for Food Safety and Applied Nutrition, food policy office, and certain functions of its regulatory affairs office, agency head Robert M. Califf announced. The changes were aligned with several recommendations made last year by the Reagan-Udall Foundation, an organization in part funded by FDA, that assessed how the agency could shore up its food operations.